Meyka Pro banner
Transchem Limited

Transchem Limited (TRANSCHEM.BO) Stock Overview

Explore Transchem Limited’s financial performance, market position, analyst ratings, and future outlook.

TRANSCHEM.BOBSE
HealthcareMedical - Pharmaceuticals
319.00
11.75(3.82%)
Indian Market opens in 14h 37m

Transchem Limited (TRANSCHEM.BO)

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio58.11
EPS (TTM)$3.77
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$325.15
3 Months$242.16
1 Year Target$154.21

TRANSCHEM.BO Stock Analysis & Investment Overview (BSE)

Our AI-powered analysis of Transchem Limited (BSE: TRANSCHEM.BO) gives investors deep insight into how the stock performs on the BSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Transchem Limited's BSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TRANSCHEM.BO on the BSE shows an RSI of 50.37, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $154.21 for the BSE listing.

Key metrics behind Transchem Limited's BSE-traded stock include a P/E ratio of 58.11 and a market capitalization of 3.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TRANSCHEM.BO on the BSE.

Price Performance (BSE: TRANSCHEM.BO)

1-Day Change
3.82%
5-Day Change
4.59%
1-Month Change
-6.47%
3-Month Change
60.34%
6-Month Change
121.45%
Year-to-Date (YTD) Change
74.21%
1-Year Change
705.76%
3-Year Change
1262.08%
5-Year Change
1129.29%
All-Time (Max) Change
1141.25%

Contact Information

+91 22 2633 5583
111, Maker Chambers IV, 11th Floor, Thane, MA, 400021

Company Facts

120 Employees
IPO DateFeb 16, 2000
CountryIN
Actively Trading

Frequently Asked Questions